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Cellular Biology
Abolishing Myofibroblast Arrhythmogeneicity by
Pharmacological Ablation of -Smooth Muscle Actin
Containing Stress Fibers
Christian Rosker, Nicolo` Salvarani, Stephan Schmutz, Teddy Grand, Stephan Rohr
Rationale: Myofibroblasts typically appear in the myocardium after insults to the heart like mechanical overload
and infarction. Apart from contributing to fibrotic remodeling, myofibroblasts induce arrhythmogenic slow
conduction and ectopic activity in cardiomyocytes after establishment of heterocellular electrotonic coupling in
vitro. So far, it is not known whether -smooth muscle actin (-SMA) containing stress fibers, the cytoskeletal
components that set myofibroblasts apart from resident fibroblasts, are essential for myofibroblasts to develop
arrhythmogenic interactions with cardiomyocytes.
Objective: We investigated whether pharmacological ablation of -SMA containing stress fibers by actin-targeting
drugs affects arrhythmogenic myofibroblast–cardiomyocyte cross-talk.
Methods and Results: Experiments were performed with patterned growth cell cultures of neonatal rat
ventricular cardiomyocytes coated with cardiac myofibroblasts. The preparations exhibited slow conduction and
ectopic activity under control conditions. Exposure to actin-targeting drugs (Cytochalasin D, Latrunculin B,
Jasplakinolide) for 24 hours led to disruption of -SMA containing stress fibers. In parallel, conduction velocities
increased dose-dependently to values indistinguishable from cardiomyocyte-only preparations and ectopic
activity measured continuously over 24 hours was completely suppressed. Mechanistically, antiarrhythmic effects
were due to myofibroblast hyperpolarization (Cytochalasin D, Latrunculin B) and disruption of heterocellular
gap junctional coupling (Jasplakinolide), which caused normalization of membrane polarization of adjacent
cardiomyocytes.
Conclusions: The results suggest that -SMA containing stress fibers importantly contribute to myofibro-
blast arrhythmogeneicity. After ablation of this cytoskeletal component, cells lose their arrhythmic effects
on cardiomyocytes, even if heterocellular electrotonic coupling is sustained. The findings identify -SMA
containing stress fibers as a potential future target of antiarrhythmic therapy in hearts undergoing
structural remodeling. (Circ Res. 2011;109:1120-1131.)
Key Words: arrhythmia  conduction  fibroblast  gap junction  myocardial structure
Fibrotic remodeling of the working myocardium is acommon consequence of various insults to the heart
like pressure/volume overload, infarction, genetic predis-
position, and old age.1 Apart from compromising mechan-
ical function, fibrotic remodeling is a major cause of
cardiac arrhythmias. Arrhythmogenesis in fibrotically re-
modeled hearts is thought to be due to the disruption of the
normally dense and orderly three-dimensional cytoarchi-
tecture of parenchymal cells by excessive amounts of
extracellular matrix (ECM) produced by stromal cells. The
resulting disorganization of the electrically excitable sub-
strate causes slow conduction (discontinuous and/or “zig-
zag” conduction) and conduction blocks that contribute to
the precipitation of arrhythmias.2,3 Stromal cells responsi-
ble for fibrotic remodeling include so-called myofibro-
blasts (MFBs), which contribute to fibrosis by hypersecre-
tion of ECM proteins.4 MFBs, which are not normally
present in healthy myocardia, typically appear in the
context of the pathologies mentioned and tend to locally
persist for extended periods of time.
Apart from contributing to fibrotic remodeling, MFBs
recently came into focus as a cell type that might directly
contribute to arrhythmogenesis based on adverse electrotonic
interaction with cardiomyocytes (CMCs). MFBs were shown
in vitro to establish heterocellular gap junctional coupling
with CMCs based on connexin 45 and connexin 43 expres-
sion.5 Because MFBs have a reduced membrane potential as
compared to CMCs, heterocellular gap junctional coupling
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leads to depolarizing current flow from MFBs to CMCs that
causes a reduction of the resting membrane potential of
CMCs similar to the concept of “injury current flow” in the
setting of an infarction.6 This results in slow conduction
because of sodium channel inactivation and induces ectopic
activity based on “depolarization-induced automaticity.”5,7
By inducing both slow conduction and ectopic activity, MFBs
might contribute importantly to arrhythmogenesis in hearts
undergoing fibrotic remodeling.
MFBs differ from normal resident cardiac fibroblasts by
de novo expression of -smooth muscle actin containing
stress fibers (-SMA-SFs).8 Given that fibroblasts in intact
healthy hearts obviously exert no arrhythmogenic effects
on neighboring CMCs, we hypothesized that disruption of
-SMA-SFs by appropriate pharmacological tools not only
might revert the MFB phenotype towards fibroblast-like
cells but that it might particularly abolish their arrhythmo-
genic interaction with CMCs. Stress fibers are subject to
constant turnover with dynamics determined by the rate of
addition of monomeric actin (G-actin) to the fast-growing
(barbed) end and the dissociation of actin at the opposite
(pointed) end of filamentous actin (F-actin). This process,
referred to as “treadmilling,” can be modulated by a number
of actin-targeting compounds. Among these, Latrunculin B
(LatB) blocks formation of actin fibers by sequestering
G-actin, whereas Cytochalasin D (CytoD) interacts with the
barbed ends of actin filaments (“capping”), thereby inhibiting
G-actin binding.9,10 By contrast, Jasplakinolide (Jasp) stabi-
lizes F-actin and facilitates actin polymerization.11,12 Using
these three agents in models of fibrotic cardiac tissue con-
sisting of CMCs coated with MFBs, we found that interfer-
ence with stress fiber turnover reduced MFB-induced ectopic
activity and increased conduction velocities () to values
indistinguishable from CMC-only preparations. The findings
suggest that -SMA–decorated stress fibers not only identify
fibroblastic cells as MFBs but that this cytoskeletal compo-
nent is a potentially important determinant of MFB
arrhythmogeneicity.
Methods
A detailed description of the methodologies used in this study is provided in
the Online Supplement (available at http://circres.ahajournals.org).
Cell Culture
Patterned growth primary cultures of neonatal rat ventricular CMCs
were obtained using previously published procedures.13 In short,
small tissue pieces from neonatal rat ventricles were subjected to
trypsin dissociation. The resulting cell suspension was preplated for
2.2 hours in cell culture flasks to separate fast-adhering fibroblasts
from slowly adhering CMCs. CMCs were seeded on photolitho-
graphically pretreated coverslips, which were patterned with colla-
gen to result in strands (0.610 mm) or discs (10-mm diameter) of
CMC monolayers. After 24 hours in culture, a subset of preparations
was coated with MFBs. Pharmacological interventions were per-
formed 24 hours later.
Optical Measurement of Impulse Conduction
The characteristics of impulse conduction along strand preparations
were assessed using multiple site optical recording of transmembrane
voltage. Preparations stained with the voltage sensitive dye di-8-
ANEPPS were mounted in a temperature-controlled experimental
chamber that was placed on the stage of a dedicated optical recording
system.14 Recordings were obtained after prestimulating the prepa-
rations with an extracellular electrode for 10 seconds at 2 Hz for
conduction to reach steady-state. Optically recorded action potential
amplitudes were normalized (%APA) and maximal upstroke veloc-
ities (dV/dtmax) were calculated in relation to these values (%APA/ms).
Under the assumption of an average APA of 100 mV, %APA/ms
corresponds to V/s.
Videomicroscopic Long-Term Measurement of
Ectopic Activity
The frequency of ectopic activity of disc-shaped preparations was
assessed continuously for extended periods of time by recording
spontaneous contractile activity with a novel custom-made vid-
eomicroscopy system installed in an incubator. Beat rates were
determined in up to 24 preparations in parallel and stored together
with phase contrast images of the recording sites for offline
analysis and for the generation of time-lapse movies. After
control recordings lasting for 4 hours, the culture medium was
exchanged (with or without drugs) and the effects of pharmaco-
logical interventions on spontaneous activity were assessed dur-
ing the next 24 hours.
Patch Clamp Recording
Resting membrane potentials and current–voltage relationships were
recorded using whole-cell patch clamp recording in sparsely seeded
cell cultures. Membrane potentials reported for CMC–MFB cell
pairs were obtained in CMCs. Gap junctional communication was
probed by dye diffusion experiments.
Immunocytochemistry
The phenotype of fibroblastic cells was routinely assessed using
standard immunocytochemistry with antibodies directed against
-SMA and vimentin. Nuclei were counterstained with 4,6-
diamidino-2-phenylindole (DAPI).5
Statistics
Values are given as meanSD. Data were compared using the
Student t test (two-tailed; homoscedastic or heteroscedastic where
appropriate), and differences were considered significant at P0.05.
Results
Effects of Actin-Targeting Drugs on
MFB Morphology
Cardiac fibroblasts cultured on rigid glass substrates under-
went a rapid phenotype switch to MFBs, which accounted
Non-standard Abbreviations and Acronyms
-SMA-SF alpha smooth muscle actin containing stress fiber
 conduction velocity
ATD actin-targeting drugs
CMC cardiomyocyte
CytoD Cytochalasin D
DAPI 4=,6-diamidino-2-phenylindole
dV/dtmax maximal action potential upstroke velocity
ECM extracellular matrix
Jasp Jasplakinolide
LatB Latrunculin B
MFB myofibroblast
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for 90% of the initially seeded cells after 24 hours in
culture (Figure 1A, control). Typically, these cells had a
flattened and outspread morphology and displayed abun-
dant stress fibers that stained intensely for -SMA. When
treated with drugs that interfere with actin turnover,
-SMA expression was reduced and targeting to stress
fibers was severely compromised or completely lost. As
shown in Figure 1A, exposure of MFBs for 24 hours to
CytoD and LatB (100 nmol/L each) caused a reduction and
redistribution of -SMA from stress fibers to the tips of
cellular protrusions, whereas Jasp (1 mol/L) induced the
formation of condensed fragments of -SMA (“ag-
gresomes”)15 that were scattered throughout the cells. As
shown in Figure 1B, actin-targeting drugs (ATDs) at these
concentrations reduced the percentage of cells with an
MFB phenotype by 57% (CytoD) and 90% (LatB and Jasp,
respectively), thus resulting in partial reversal of the
phenotype switch observed initially in cell culture. In
addition to the reduction and reorganization of -SMA,
ATDs induced characteristic changes in MFB morphology
as revealed by time-lapse microscopy (movies in Online
Data Supplement). During the first hour of exposure to 100
nmol/L CytoD, MFBs tended to lose their normally flat
and outspread morphology and became spherical while
remaining physically anchored to the substrate by thin
cytoplasmic extensions. This change was transient as cells
recovered a flattened shape over the remainder of the
observation period (15 hours). At identical concentra-
tions, LatB caused similar morphological changes. How-
ever, the onset was acute and the loss of the flat and
outspread cell morphology became increasingly pro-
nounced during the initial 7 hours of drug exposure, after
which time cells regained a flat and outspread morphology.
In contrast to these transient effects of CytoD and LatB on
MFB morphology, Jasp caused the flat and outspread
MFBs to adopt an increasingly dendritic morphology that
showed no tendency for reversal in the presence of the
drug.
Because the rigidity of the culture substrate is an
important determinant of the transformation of fibroblasts
to MFBs,16 we investigated whether ATDs were equally
effective when applied to fibroblasts cultured on top of
“soft” monolayers of CMCs. Similar to glass substrates,
fibroblasts adhering to CMCs underwent a rapid phenotype
switch to MFBs and formed a uniform cell coat after 48
hours in culture (Figure 2, control). Treating the prepara-
tions with CytoD or LatB (100 nmol/L each for 24 hours)
caused -SMA-SFs to disappear almost completely,
whereas Jasp (1mol/L for 24 hours) again induced the
formation of -SMA aggresomes (Figure 2). All three
drugs reduced the number of cells displaying -SMA
positive stress fibers by 95%, suggesting that they were
more effective in inducing a phenotype reversal in the
setting of soft as opposed to rigid substrates. Irrespective
of the type of treatment, the density of vimentin-positive
fibroblastic cells remained largely unchanged, which indi-
cates that the decline of cells with an MFB phenotype was
not due to a drug-induced cell loss but rather reflected the
presence of “back-transformation” of MFBs to fibroblasts.
Actin-Targeting Drugs Rescue MFB-Induced
Slow Conduction
As shown before, MFBs cultured on top of monolayer strands
of CMCs induce slow conduction based on their depolarizing
effect on CMCs after establishment of heterocellular electro-
tonic coupling.5 We hypothesized that MFBs might lose this
arrhythmogenic effect after disruption of their structural
hallmark, ie, of -SMA-SFs. For this purpose, strands of
CMCs coated with MFBs were subjected for 24 hours to
LatB, CytoD, and Jasp, and resulting effects on  and
dV/dtmax of propagating action potentials were assessed
optically. Figure 3A shows raw data of an experiment in
which conduction in an untreated MFB–CMC strand is
compared to an MFB–CMC strand exposed for 24 hours to
100 nmol/L CytoD. Typically, the control strand displayed
slow overall  (202 mm/s) and slow dV/dtmax
(39.57.1%APA/ms). By contrast, the CytoD-treated MFB–
Figure 1. Actin-targeting drugs reduce -smooth muscle
actin containing stress fibers (-SMA-SFs) in MFBs. A,
Micrographs of cardiac MFBs cultured on glass substrates.
Preparations were stained with antibodies against -SMA
(green) and counterstained with DAPI (blue). Control cells
exhibit abundant -SMA–positive stress fibers. Following
incubation for 24 hours with CytoD (100 nmol/L), LatB (100
nmol/L), and Jasp (1 mol/L), -SMA staining is reduced and
the MFB-specific association with stress fibers is mostly lost,
indicating that cells regain a fibroblast phenotype. B, Reduc-
tion of the percentage of cells displaying -SMA decorated
stress fibers by CytoD, LatB, and Jasp treatment (same con-
ditions as in A). n, number of analyzed fields of view in 4
preparations from 2 cultures each; *P0.05 vs control.
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CMC strand exhibited a substantial increase of  (370 mm/s)
and dV/dtmax (77.81.7%APA/ms). The dose–response
curve for CytoD-induced restoration of  and dV/dtmax
revealed an EC50 of 3 nmol/L, with maximal effects
reached at 100 nmol/L (Figure 3B). At this concentration,
 (3796 mm/s; n48) and dV/dtmax (781%APA/ms;
n48) became virtually indistinguishable from CMC-only con-
trol strands (36520 mm/s; dV/dtmax792%APA/ms;
n72), indicating that CytoD caused complete elimination of
MFB-induced slow conduction. This effect was most likely due
to a specific action of CytoD on MFBs because exposure of
CMC-only control strands to 100 nmol/L CytoD for 24 hours
failed to induce significant changes in action potential
propagation.
Similar to CytoD, LatB completely eliminated adverse effects
of MFBs on impulse conduction in MFB–CMC strands (Figure
3C). The EC50 of LatB for increasing  and dV/dtmax was 10
nmol/L, with maximal effects reached at 100 nmol/L. Nor-
malization of conduction by LatB was due to its specific effects
on MFBs because it failed to induce alterations in action
potential propagation characteristics in CMC-only preparations.
At dosages above the maximal effective concentration (1 and
10 mol/L), LatB caused an increasing reduction of , whereas
dV/dtmax was only minimally affected, suggesting that LatB
possibly decreased gap junctional coupling among CMCs at
these high concentrations.
In contrast to CytoD and LatB, which destabilize F-actin,
Jasp is thought to stabilize F-actin. Accordingly, this com-
Figure 2. Effects of ATDs on -SMA expression of MFBs cultured on top of CMCs. CMC monolayer cultures coated with cardiac
fibroblasts were double-labeled for -SMA (red), vimentin (green), and counterstained with DAPI (pink; overlaid on phase contrast
image). Under control conditions, fibroblasts form a dense coat of vimentin-positive cells that display abundant -SMA–positive stress
fibers indicating that fibroblasts had undergone a phenotype switch to MFBs. After treatment with CytoD, LatB, and Jasp at indicated
concentrations for 24 hours, -SMA decorated stress fibers are no longer present with the exception of a few cells (white arrowheads).
At the same time, the density of vimentin-positive cells remains largely unchanged, indicating that MFBs regained a fibroblast-like phe-
notype during drug treatment.
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pound was expected to have opposite or no impact on impulse
conduction characteristics in MFB-coated CMC strands. Sur-
prisingly, however, Jasp acted like CytoD and LatB and
caused a restoration of impulse conduction in MFB-coated
CMC strands with an EC50 of300 nmol/L. Maximal effects
were observed at 1 mol/L, where  (36616 mm/s; n48)
was slightly higher and dV/dtmax (702%APA/ms; n48)
was slightly lower than values recorded in the corresponding
control CMC strands (32822 mm/s; dV/
dtmax763%APA/ms; n84). At maximal effective con-
centrations (1 mol/L), Jasp also affected impulse propaga-
tion in CMC-only strands, where it induced a significant
increase of  (37918 mm/s vs 32822 mm/s in controls)
that was accompanied by a slight increase in dV/dtmax
(782%APA/ms vs 763%APA/ms in controls; not
significant).
Suppression of Ectopic Activity by
Actin-Targeting Drugs
It was shown before that MFBs cultured at sufficient
densities on top of dense monolayers of ventricular CMCs
induce ectopic activity.7 As for MFB-induced slowing of
conduction, induction of ectopic activity by MFBs is based
on partial depolarization of CMCs after establishment of
heterocellular electrotonic coupling, which leads to precip-
itation of spontaneous activity because of “depolarization
Figure 3. ATDs abolish MFB-induced
slow conduction. A, Typical example of a
voltage sensitive dye measurement of
impulse propagation along a control
MFB–CMC strand (left) and an MFB–CMC
strand exposed to 100 nmol/L CytoD for
24 hours (right). Round circles on the
phase-contrast images indicate the posi-
tions of individual photodetectors.
Upstrokes of a propagating action poten-
tial elicited on the far left are shown. The
 was calculated from the graph of local
activation times versus distance. CytoD
treatment resulted in a substantial
increase of maximal upstroke velocities
(dV/dtmax) and conduction velocities () to
values indistinguishable from control CMC
strands. B–D, Dose–response relation-
ships for the effects of CytoD, LatB, and
Jasp on  and dV/dtmax. Control values
for CMC (red) and MFB–CMC (green)
preparations are given on the left of each
diagram, with values (averageSD)
extended as bars to the right for compari-
son purposes. The effects of individual
drugs are indicated by black discs that
were fitted by eye (dotted line). Data are
averageSD; n48 for each data point.
*P0.05.
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induced automaticity.”17 Given these mechanistic similar-
ities, actin-targeting drugs were expected to suppress
ectopic activity at concentrations similar to those found to
be maximally effective in rescuing slow conduction. This
hypothesis was tested with disc-shaped monolayer prepa-
rations (10-mm diameter) consisting of CMCs only and of
CMCs coated with MFBs in which we recorded synchro-
nized spontaneous contractile activity continuously for 28
hours under stable incubating conditions using a custom-
made videomicroscopy recording system.
With the exception of a few sporadic activations, CMC-
only preparations remained completely quiescent during
the entire 28-hour recording period irrespective of the
addition of drugs (Figure 4A–C, left panels). By contrast,
MFB–CMC preparations exhibited regular spontaneous
activity during the control recording period with frequen-
cies ranging from 50 to 80 beats per minute. After
exchange of the culture medium, control MFB–CMC
preparations receiving no drugs showed a transient in-
crease of BPM to 80 –100, which displayed multiple
phases: a fast initial increase in beat frequency peaking
1.5 hours after the medium exchange was followed by a
slight decline and a subsequent slower increase, with
maximal frequencies attained at 6 hours. Thereafter, beat
frequencies declined monotonically to values comparable
to those recorded before the medium exchange. This
characteristic evolution of frequencies in control prepara-
tions was substantially altered by the addition of CytoD,
LatB, and Jasp. All three drugs caused a reduction in beat
frequencies to zero (CytoD and LatB) or close to zero
(Jasp), albeit with different time courses (Figure 4A–C,
right panels). When normalized to average beats per
minute values recorded before addition of the drugs,
CytoD progressively reduced spontaneous activity with
complete cessation occurring after 18 hours (time constant,
 9.7 hours). Equimolar concentrations of LatB were
more effective because the drug caused acute depression of
activity (25%) that was accentuated over time following
a sigmoidal time course until complete cessation of spon-
taneous activity occurred after 10 hours ( 3.2 hours).
In contrast to both CytoD and LatB, Jasp displayed a
substantial latency in the onset of decrease of ectopic
activity (4 hours). Of note, beat frequencies during the
initial 2 hours after addition of the drug were consistently
Figure 4. Inhibition of MFB-induced ecto-
pic activity by ATDs. A, Evolution of the
frequency of spontaneous activity during
exposition of MFB–CMC preparations to
100 nmol/L CytoD (n7). Left, Time course
of the frequency of spontaneous activity
before (control period) and after drug addi-
tion to MFB–CMC preparations (black dots,
control preparations; red dots, treated prep-
arations) and CMC-only preparations (green
diamonds, control preparations; yellow dia-
monds, treated preparations). At the time of
drug addition, all preparations received a
medium exchange. Right, Evolution of fre-
quencies of spontaneous activity normalized
to frequencies recorded during the control
period in MFB–CMC preparations (black
dots, control preparations; red dots, treated
preparations). The time course of fractional
changes in beat frequencies of treated vs
control preparations is indicated by blue
diamonds. B, Same as (A) for 100 nmol/L
LatB (n9). C, Same as (A) for 1 mol/L
Jasp (n11).
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higher in Jasp-treated preparations than in controls. After
this phase, spontaneous activity progressively decayed
with near-complete loss of activity being reached after 24
hours ( 13.7 hours).
Mechanisms of Antiarrhythmic Activity of
Actin-Targeting Drugs
Given that both the extent of conduction slowing and the
likelihood of occurrence of ectopic activity induced by MFBs
is a function of the amount of depolarizing current flow from
MFBs to CMCs, suppression of these effects by actin-
targeting drugs may depend on a reduction in MFB density, a
loss of gap junctional coupling between MFBs and CMCs, or
a change in MFB electrophysiology (or a combination of
these).
To investigate whether CytoD, LatB, and Jasp caused a
loss of MFBs secondary to their effects on cell morphology,
counts of DAPI stained nuclei of the preparations used for the
experiments depicted in Figure 3 were used as an index of cell
densities present during the different interventions. Whereas
DAPI staining is an indirect measure of cell number (no
differentiation between mononucleated and multinucleated
cells), the usefulness of the index is illustrated by the finding
that the excess number of nuclei in MFB–CMC versus
CMC-only preparations (	46%) approximately mirrors the
number of fibroblasts seeded on top of CMC monolayers to
obtain MFB–CMC preparations (	38% cells). As shown in
Figure 5, CytoD had no effect on nuclear counts at concen-
trations as high as 10 mol/L. By contrast, both LatB and
Jasp led to a slight decrease of the number of nuclei at
concentrations being maximally effective in suppressing ar-
rhythmogenic slow conduction and ectopic activity (LatB 100
nmol/L:9%; Jasp 1 mol/L:12%; not significant). Given
the only modest reductions in nuclei counts for LatB and
Jasp, it is unlikely that either of these compounds led to a
sufficiently large decrease in the number of MFBs to explain
the observed antiarrhythmic effects.
The question of whether ATDs induced a loss of gap
junctional communication between MFBs and CMCs was
investigated by assessing intercellular diffusion of lucifer
yellow in MFB–CMC preparations under control condi-
tions (Figure 6A) and after exposition to CytoD (100
nmol/L; Figure 6B), LatB (100 nmol/L; Figure 6C), and
Jasp (1 mol/L; Figure 6D) for 24 hours. Under control
conditions, intercellular diffusion was present in 91% of
MFB–CMC preparations (n23; Figure 6A). Similarly,
lucifer yellow diffusion was found in 80% of preparations
exposed to CytoD (n10) and in 82% of preparations
exposed to LatB (n11). In contrast, dye diffusion was
completely blocked after treatment with Jasp (n8). These
findings suggest that disruption of heterocellular gap
junctional communication is likely responsible for the
antiarrhythmic activity of Jasp, whereas CytoD and LatB
exerted their effects by a different mechanism.
The possibility that actin-targeting drugs reduced MFB
arrhythmogeneicity by affecting membrane polarization of
CMCs and/or MFBs was investigated using whole-cell
patch clamp recordings in low-density cell cultures ex-
posed to actin-targeting drugs for 24 hours. As shown in
Figure 7A, exposure of CMCs to CytoD, LatB, and Jasp
(1 mol/L each) had no significant effects on CMC resting
potentials (control: 74.63.3 mV; CytoD: 73.35.9
mV; LatB: 73.24.6 mV; Jasp: 73.56.0 mV; n5
each). By contrast, ATDs induced a significant hyperpo-
larization of MFBs (control: 26.67.2 mV; CytoD:
44.512.3 mV; LatB: 40.59.8 mV; Jasp: 42.09.1
mV; n5 each). As could be expected, MFB hyperpolar-
ization caused a corresponding hyperpolarization of MFB–
CMC cell pairs (control: 63.012.0 mV; CytoD:
72.510.3 mV; LatB: 73.0.56.7 mV; Jasp:
73.49.8 mV; n7 each; for an extended discussion of
electrotonic CMC–MFB interactions, see Online Supple-
ment). Given that cell pairs exposed to Jasp were not likely
coupled by gap junctions any more, the value shown for
this particular drug most likely reflects the membrane
polarization of the patched CMCs alone. As shown by
typical I–V curves obtained from single MFBs (Figure
7B), ATD-induced MFB hyperpolarization was based on a
reduction of net inward currents at negative membrane
potentials. When tested at holding potentials of 60 and
75 mV, these reductions amounted to 66/68% for
CytoD, 57/65% for LatB, and 40/52% for Jasp,
Figure 5. Reduction of cell number by ATDs. Strand preparations used in optical measurements of impulse propagation depicted in
Figure 3 were stained with DAPI for assessing changes in the number of nuclei after exposure of the preparations to CytoD (A), LatB
(B), and Jasp (C) at the concentrations indicated. Gray bars denote MFB–CMC preparations not exposed to drugs, whereas white bars
(labeled CMC) indicate the number of nuclei in CMC-only strands for comparison purposes. Values are normalized to control MFB–
CMC preparations (averageSD; n5–10 for each data point). *P0.05.
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respectively (Figure 7C). Determinations of membrane
capacities of the cells in Figure 7C indicated that drug
treatments did not significantly affect average cell sizes
(control: 60.115.5 pF; CytoD: 57.521.4 pF; LatB:
50.127.5 pF; Jasp: 65.823.8 pF). In contrast to MFBs,
exposing CMCs to ATDs had no effect on CMC net
membrane currents recorded under identical conditions.
Discussion
The results of this study demonstrate that reverting the
phenotype of cardiac MFBs to fibroblasts by pharmacological
ablation of -SMA-SFs abolishes their arrhythmogenic inter-
action with CMCs. This effect depends primarily on the
hyperpolarization of cells undergoing depletion of -SMA-
SFs, which reveals a novel function of this cytoskeletal
component in MFBs. Cardiac fibroblasts emerging from
back-transformation of MFBs exert no adverse effects on
CMC electrophysiology, even though remaining electrically
coupled. Apart from conveying increased contractility,18 the
presence of -SMA hence appears instrumental for determin-
ing MFB arrhythmogeneicity.
Pharmacological Transformation of MFBs
to Fibroblasts
Under physiological conditions, connective tissue fibro-
blasts in organs as different as the skin, the liver, and the
lungs are shielded from mechanical stress by the surround-
ing ECM. As a consequence, they generally lack stress
fibers and display a mostly dendritic morphology.19 These
features are retained when fibroblasts are cultured at
moderate densities in three-dimensional collagen matrices
where they form an in vivo-like network of dendritically
shaped cells that are metabolically coupled.20 The pheno-
type of fibroblasts changes drastically when cells are
exposed to mechanical stress as typically present in vivo
during tissue repair and in vitro when cultured on rigid
substrates or on top of CMCs.5 These conditions present
fibroblasts with mechanical cues that initiate a rapid
phenotype switch to MFBs that express abundant -SMA–
positive stress fibers.21,22 As found in the present study,
exposing MFBs to ATDs reverses the phenotype switch by
reducing the abundance of -SMA and its targeting to
stress fibers. While the reduction of -SMA-SFs was the
expected result for the F-actin destabilizing drugs CytoD
and LatB, Jasp exerted similar effects despite its reported
function as an F-actin stabilizer. With Jasp, we observed a
loss of stress fibers and the appearance of actin-aggregates
that were scattered throughout the cytoplasm. This obser-
vation is consistent with earlier findings in rat embryonic
fibroblasts and Vero cells, where treatment with Jasp for
24 hours caused disappearance of stress fibers and forma-
tion of actin “aggresomes.” Mechanistically, this effect has
been explained by a Jasp-induced increase in actin nucle-
ation frequency that causes a critical reduction in G-actin
and results in the formation of disordered polymeric actin
that is stored in F-actin– enriched pathological inclusion
bodies.12,15 Apart from reducing -SMA expression and
targeting to stress fibers, actin-targeting drugs caused
MFBs to adopt a fibroblast-like dendritic morphology
either transiently (CytoD, LatB) or permanently (Jasp)
during the 24-hour exposure period. Such morphological
changes are not specific for MFBs but have previously
been reported for a wide range of other adherent cell types.
Whereas the transient nature of the effect of LatB on cell
morphology was proposed to depend on progressive serum
inactivation of the drug,23 it remains to be shown why
morphological effects of CytoD were similarly transient.
Figure 6. Intercellular dye diffusion in MFB–CMC preparations after treatment with ATDs. A, Diffusion of lucifer yellow under con-
trol conditions in a cell network consisting of CMCs and MFBs as assessed 8 minutes after injection of the CMC marked with a yellow
“pipette.” B–D, Same as (A) for preparations subjected for 24 hours to CytoD, LatB (100 nmol/L), and Jasp (1 mol/L).
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Pharmacological Interference With F-Actin
Turnover Reduces MFB Arrhythmogeneicity
In the past, the direct demonstration that MFBs, but not
fibroblasts, exert arrhythmogenic effects on CMCs was ham-
pered by the fact that cardiac fibroblasts in standard primary
cell culture have a pronounced tendency to undergo a
phenotype switch to MFBs.24,25 Given the possibility to
pharmacologically ablate -SMA-SFs and, as a result, back-
transform MFBs to fibroblasts, we investigated to which
extent this intervention might affect MFB-dependent slow
conduction and ectopic activity. Irrespective of the type of
actin-targeting drug used, ablation of -SMA-SFs consis-
tently led to complete suppression of MFB arrhythmogene-
icity. Specifically, all three drugs caused normalization of 
and dV/dtmax in hybrid MFB–CMC preparations to values
that were indistinguishable from CMC-only control strands.
Restoration of impulse conduction by ATDs was dose-
dependent, with drugs exhibiting an EC50/maximal effective
concentration of 3/100 nmol/L (CytoD), 10/100 nmol/L
(LatB), and 300/1000 nmol/L (Jasp). The finding that none of
the drugs affected impulse conduction in CMC-only prepa-
rations to any major extent at maximally effective concentra-
tions demonstrates that amelioration of conduction by actin-
targeting drugs was predominantly achieved though their
action on MFBs. A similar scenario was observed in regard to
MFB-induced ectopic activity. When used at maximally
effective concentrations, all three drugs led to increasing
depression and finally complete cessation of ectopic activity.
As revealed by a newly developed recording device that
permits combined video time-lapse recordings and long-term
assessments of spontaneous contractile activity under stable
incubating conditions, the time course of depression of
ectopic activity showed characteristic differences for the
three actin-targeting drugs used in regard to the onset of
action (LatB, acute; CytoD delayed by 0.8 hours; Jasp
delayed by 2 hours) and the time constant of depression of
the frequency of ectopic activity (LatB, 3.2 hours; CytoD, 9.7
hours; Jasp, 13.7 hours). As demonstrated by time-lapse
video recordings, acute depression of ectopic activity by LatB
was paralleled by an equally acute change of MFB morphol-
ogy, with cells transiently losing their outspread morphology.
Whether and by which mechanisms the acute change in
Figure 7. ATDs affect MFB electrophysiology. A, Resting membrane potentials (RMPs) recorded in CMCs (left), MFBs (middle panel),
and MFB–CMC cell pairs (right) under control conditions and after exposure to CytoD, LatB, and Jasp at 1 mol/L each for 24 hours.
B, Current–voltage relationships for MFBs under control conditions and after exposure to actin-targeting drugs. C, Average currents
recorded at holding potentials of 60 and 75 mV in MFBs (upper) and CMCs (lower) under control conditions and after exposure to
actin-targeting drugs. Values: average  SD. *P0.05; **P0.005.
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morphology can explain the acute change in ectopic activity
remains to be shown. Overall, even though all three actin-
targeting drugs share a common end point in regard to
suppressing MFB arrhythmogeneicity, their different modes
of action are partially reflected by differences in maximally
effective concentrations (Jasp  CytoD, LatB) and the time
constant of suppression of ectopic activity (Jasp  CytoD 
LatB). Of note, Jasp, which might initially have stabilized
F-actin, was the only drug that transiently increased ectopic
activity during the first 2 hours above control levels, suggest-
ing that stabilization of stress fibers might be proarrhythmo-
genic. Whether this effect was related to Jasp-induced acute
changes in gap junctional coupling remains to be shown. In
summary, the findings suggest that -SMA-SFs are condu-
cive for myofibroblasts arrhythmogeneicity. This conclusion
is supported by a recent study in which cultured cardiac
fibroblasts that did not express -SMA-SFs showed only
little adverse effects on the electrophysiology of cocultured
cardiomyocytes.25
Mechanisms Underlying Actin-Targeting
Drug-Induced Reduction of
MFB Arrhythmogeneicity
In principle, the antiarrhythmic effects of ATDs can be
explained by an action on CMCs, MFBs, or a combination
thereof. Regarding CMCs, the finding that actin-targeting
drugs at maximally effective concentrations had little if any
effect on resting membrane potentials, impulse conduction
parameters, and spontaneous activity in CMC-only prepara-
tions, suggests that this cellular compartment was not in-
volved. This leaves MFBs as cellular targets in which
antiarrhythmic ATD activity can be explained by (i) a
reduction of the number of MFBs, (ii) a reduction of
heterocellular gap junctional coupling, and/or (iii) a hyperpo-
larization of MFBs. Ad (i): Even though, in principle, all
three ATDs are capable of inducing apoptosis when used at
sufficiently high concentrations, cell numbers as indirectly
inferred from the count of DAPI–stained nuclei were not
significantly altered at maximally effective concentrations.
Similarly, ATD treatment for 24 hours did not substantially
change the density of vimentin-positive cells in hybrid
preparations. Accordingly, it seems safe to conclude that
ATDs did not act via a reduction of MFB cell number. Ad
(ii): As qualitatively illustrated by persistence of dye diffu-
sion after exposure to CytoD and LatB, gap junctional
coupling was not affected to any major degree by these two
drugs. In contrast, Jasp caused complete disruption of MFB–
CMC communication while leaving gap junctional coupling
among CMCs unaffected as evidenced by a lack of depres-
sion of . The discrepancy between CytoD/LatB and Jasp
may be explained by the Jasp-specific induction of a highly
dendritic cell type that possibly disrupted gap junctional
communication with CMCs. Ad (iii): In contrast to their lack
of effect on CMC resting membrane potentials, ATDs in-
duced a significant hyperpolarization of MFBs from 25
mV to 40 mV that was accompanied by a substantial
reduction of net inward currents at negative potentials, with
Jasp being slightly less effective than CytoD/LatB (range,
41% to 66%). In principle, these findings can be ex-
plained by a reduction of depolarizing inward currents or an
increase in hyperpolarizing outward currents secondary to the
disruption of the cytoskeleton by actin-targeting drugs (or a
combination of these). Among the different cytoskeletal
components, actin filaments seem particularly important in
this context because their breakdown has been shown to
affect ion channels and exchangers in a way that could
explain observed effects: BKCa (upregulation);26,27 L-type
Ca2	 channels (downregulation);28,29 Na	/Ca	 exchanger
(upregulation of reverse-mode activity);29,30 and TRP
channels (complex effects including downregulation).31,32
In an attempt to understand which ion channels, exchang-
ers, and pumps might be involved in the effects of -SMA-SF
disruption on myofibroblast electrophysiology under our exper-
imental conditions, we performed a RT-qPCR study in which we
screened expression of 70 genes in myofibroblasts under
control conditions and after incubation with 1 mol/L CytoD
(for data and discussion, see Online Supplement). With the
exception of a single gene coding for K2P3.1 that was
significantly upregulated, the gene expression profile showed
no consistent changes between control and treated prepara-
tions that would have permitted unequivocal identification of
specific channels, exchangers, or pumps as being responsible
for the hyperpolarizing effect of CytoD on myofibroblast
electrophysiology. Similar to the RT-qPCR results, Western
blots of a selection of channels (TRPC3, TRPM4, TRPV2,
TRPV4, Kv2.1, Kir2.1, and Kir2.3; for data and discussion,
see Online Supplement) suggested that expression of these
channel proteins was not significantly altered by treating
myofibroblasts with CytoD. As an exception, CytoD treat-
ment resulted in a decrease of the complex glycosylated form
of TRPC3, which was reported before to affect channel
activity and channel targeting.33–35 Even though the combi-
nation of an increase in K2P3.1 currents and a decrease of
TRPC3-mediated currents may contribute to myofibroblast
hyperpolarization after CytoD treatment, understanding in
full which ion channels and exchangers are ultimately re-
sponsible for ATD-induced MFB hyperpolarization requires
future experiments that, given that -SMA conveys increased
contractility to MFBs, will also have to take into account the
possible involvement of mechanosensitive channels. In this
context, a further mechanism possibly contributing to the
effects of actin-targeting drugs on impulse conduction and
ectopic activity may involve a reduction of mechanical stress
exerted by myofibroblasts on cardiomyocytes after loss of
their -SMA-SFs. Reducing contractile forces of myofibro-
blasts was recently shown to restore impulse conduction
velocities in cardiomyocyte–myofibroblast preparations in a
Cx43-independent manner, suggesting that myofibroblasts
may cause slow conduction by activating mechanosensitive
channels in cardiomyocytes.36 Future studies will have to
show whether and to what extent this mechanism might
contribute to ATD-induced restoration of impulse conduction
and suppression of ectopic activity. Finally, given that previ-
ous studies showed paracrine interactions between CMCs and
fibroblastic cells with adverse consequences for CMC elec-
trophysiology, it furthermore may be warranted to investigate
whether ATDs might possibly also interfere with these
signaling pathways.37
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Limitations of the Study
The main limitation of the present study relates to the
question of to what extent the findings presented can be
extrapolated to intact diseased cardiac tissue. Apart from
possible differences in the phenotype of cultured cells versus
cells in vivo, it is still unclear whether stromal cells establish
heterocellular electrical coupling with parenchymal cells in
the intact working myocardium. Such coupling has been
suggested to be present between fibroblasts and CMCs in
healthy myocardia based on connexin immunocytochemis-
try.38 The finding of this study showing that cells devoid of
-SMA-SFs, ie, fibroblasts, neither slow impulse conduction
nor elicit ectopic activity in the continued presence of
heterocellular gap junctional coupling lends support to the
possibility that such coupling might exist in vivo. Neverthe-
less, definite extrapolation of the results will have to await
equally definite proof of heterocellular gap junctional cou-
pling in vivo.
Conclusions
The findings of this study demonstrate that the hallmark of
MFBs, -SMA-containing stress fibers are instrumental
for establishing a membrane potential depolarized enough
to permit arrythmogenic “injury current flow” to electro-
tonically coupled CMCs. Vice versa, in the absence of
-SMA-SFs, neither conduction nor excitability of cardiac
tissue is compromised, even in the sustained presence of
heterocellular gap junctional coupling. Pending direct
proof that similar functional differences between fibro-
blasts and MFBs exist in intact hearts in vivo, the findings
suggest that targeted suppression of the formation of
-SMA-SFs by using pharmacological or genetic ap-
proaches might form a valid strategy to counteract MFB
arrhythmogeneicity.
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Novelty and Significance
What Is Known?
● Following insults to the heart like mechanical overload and infarction,
normal resident fibroblasts can undergo a phenotype switch to
myofibroblasts (“activated fibroblasts”), which are characterized
by de novo expression of -smooth muscle actin containing stress
fibers (-SMA-SFs).
● In addition to their role in cardiac fibrotic remodeling, in vitro data
show that myofibroblasts induce arrhythmogenic slow conduction
and ectopic activity in cardiac tissue.
● Myofibroblast arrhythmogeneicity is based on depolarizing current
flow (“injury current flow”) from moderately polarized myofibro-
blasts to well-polarized cardiac myocytes following establishment
of heterocellular gap junctional coupling.
What New Information Does This Article Contribute?
● Pharmacological ablation of -SMA-SFs in myofibroblasts with
actin-targeting drugs (ATDs: Cytochalasin D, Latrunculin B, Jas-
plakinolide) abolishes their arrhythmogenic interactions with car-
diomyocytes in vitro.
● Suppression of myofibroblast arrhythmogenicity is likely due to a
hyperpolarization of cells undergoing disruption of -SMA-SFs,
which, in turn, causes a reduction in arrhythmogenic “injury
current flow.”
● -SMA-SFs, the structural hallmark of myofibroblasts, are instru-
mental for this cell type to exert adverse arrhythmogenic effects
on cardiac tissue.
While myofibroblasts are not present in the healthy myocardium,
they appear on myocardial injury and contribute to fibrotic
remodeling by excessive production of extracellular matrix
proteins. In vitro, myofibroblasts form heterocellular gap junc-
tions with cardiac myocytes and induce arrhythmogenic slow
conduction and ectopic activity. Given that myofibroblasts differ
from nonarrhythmogenic resident fibroblasts by expressing
-SMA-SFs, we hypothesized that pharmacological ablation of
these fibers with actin-targeting drugs might abolish myofibro-
blast arrhythmogeneicity. Exposure of hybrid myofibroblast–car-
diomyocyte preparations to ATDs led to a dose-dependent
normalization of conduction velocities and complete suppression
of ectopic activity. We found that these antiarrhythmic effects
were attributable to an ATD-induced membrane hyperpolariza-
tion (Cytochalasin D, Latrunculin B) and a loss of heterocellular
gap junctional communication (Jasplakinolide), both of which
reduce arrhythmogenic “injury current flow” from myofibro-
blasts to cardiomyocytes. These findings reveal for the first time
that the formation of -SMA-SFs in myofibroblasts promotes
arrhythmogenic slow conduction and ectopic activity in electro-
tonically coupled cardiomyocytes. Assuming that myofibro-
blasts in diseased hearts in vivo exert similar arrhythmogenic
effects, our results suggest that pharmacological ablation of
-SMA-SFs might represent a novel therapeutic strategy for
preventing arrhythmogenesis in hearts undergoing fibrotic
remodeling.
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SUPPLEMENT MATERIAL 
 
Detailed Methods 
 
Cell culture 
Cardiomyocyte preparations: Primary cultures of neonatal rat ventricular cardiomyocytes were 
prepared using previously described techniques.1 Procedures used were approved by the State Veterinary 
Department. In short, hearts from neonatal rats (Wistar, 1 day) were excised, minced with scissors and the 
resulting tissue pieces were dissociated in Hank’s balanced salt solution (HBSS without Ca2+ and Mg2+; 
Bioconcept) containing trypsin (0.12 %, Roche Diagnostics) and pancreatin (120 µg/ml, Sigma). The 
dispersed cells were centrifuged and re-suspended in culture medium consisting of M199 with Hanks' 
salts (Sigma), penicillin (20’000 U/L; Biochrom AG), streptomycin (34 µmol/L; Biochrom AG), vitamin 
B12 (1.5 µmol/L; Sigma) and 10% neonatal calf serum (Bioconcept). The resulting cell suspension was 
pre-plated for 2.2 h in large cell culture flasks under vibration-free conditions to reduce the content of 
fibroblasts that adhered more readily to the substrate than cardiomyocytes. Non-adherent cells (mostly 
cardiomyocytes) were pooled, passed through a cell strainer and vitamin C (18 µmol/L; Sigma), 
epinephrine (10 µmol/L; Sigma) and bromodeoxyridine (100 µmol/L; Sigma) were added. 
Cardiomyocytes were seeded at a density of 1.6 x 103 cells/mm2 on patterned growth substrates 
fabricated using techniques described in detail elsewhere.1 Patterns used consisted either of linear strands 
(0.6 x 4.5 mm, 24 per individual substrate) or discs (10 mm diameter; 1 per substrate). The cultures were 
kept in an incubator at 35 °C in a humidified atmosphere containing 1.2% CO2. Medium exchanges were 
performed 16 h after seeding with supplemented medium M199 (cf. above) containing a reduced amount 
of neonatal calf serum (5%).  
Low density cultures: For patch clamp experiments, freshly dissociated cells not undergoing pre-plating 
were seeded at a density of ~60 cells/mm2 on collagen coated coverslips which resulted in suitable 
numbers of single cardiomyocytes, single myofibroblasts and cardiomyocyte-myofibroblast cell pairs. 
The preparations were grown in supplemented medium M199 (cf. above) containing vitamin C (18 
µmol/L; Sigma) and epinephrine (10 µmol/L; Sigma). After 1 day, the medium was exchanged and the 
serum content was reduced to 5%. 
Hybrid cell preparations: Cardiac fibroblasts obtained during the pre-plating step described above were 
kept in the incubator for 8 days during which time they formed a dense cell monolayer that consisted 
mostly of myofibroblasts. Following dissociation of these monolayers using trypsin-containing solution 
(identical composition as that used for dissociation of cardiac tissue), cells were counted and seeded at a 
density of 5.1 x 102 cells/mm2 on 1-d old patterned cardiomyocyte preparations. After 2 h, cultures were 
washed with supplemented culture medium in order to remove non-adherent cells. Culture media 
composition was the same as that used for pure cardiomyocyte cultures except that bromodeoxyuridine 
was omitted. 
 
Drugs 
Actin targeting drugs were added to the cultures for 20 - 28 h. Drugs used included Cytochalasin D 
(CytoD; 2 mmol/L stock solution in DMSO; Sigma), Latrunculin B (LatB; 1 mmol/L stock solution in 
DMSO; Alexis), and Jasplakinolide (Jasp; 1 mmol/L stock solution in DMSO; Alexis). 
 
Immunocytochemistry 
Preparations were washed with phosphate buffered saline (PBS, Invitrogen) followed by fixation with 
methanol at -20 ºC (vimentin staining) or 2% paraformaldehyde at room temperature (α-smooth muscle 
actin staining) for 5 min. Thereafter, they were incubated for 20 min at room temperature (RT) with 
  2 
blocking buffer (PBS containing 20% goat serum) before being exposed for 2 h to anti-vimentin (mouse 
monoclonal, Sigma) or anti-α-smooth muscle actin (mouse monoclonal, Thermo Fisher) dissolved in PBS 
containing 1% goat serum and 0.15% triton X-100. After washing, preparations were incubated for 20 
min at RT with secondary antibodies (Alexa Fluor 488 and 546, goat anti-mouse, Molecular Probes) 
containing DAPI (Molecular Probes). This step was followed by washing and mounting. The preparations 
were imaged on an inverted microscope equipped for epifluorescence (Zeiss, Axiovert 200) using a slow-
scan camera (Spot RT, Diagnostic Instruments). DAPI stained nuclei were counted using appropriate 
routines of an image analysis program (ImagePro, Media Cybernetics, USA).  
  
Optical measurement of impulse conduction characteristics 
Impulse propagation characteristics were assessed optically after staining the preparations for 5 min with 
the voltage sensitive dye di-8-ANEPPS (135 µmol/L; Biotium). Stained preparations were mounted in a 
temperature controlled chamber placed on the stage of an inverted microscope (Zeiss 135M) and were 
superfused at 36°C with Hanks’ balanced salt solution (HBSS, Sigma) containing 1% neonatal calf serum 
and (mmol/L) NaCl 137, KCl 5.4, CaCl2 1.3, MgSO4 0.8, NaHCO3 4.2, KH2PO4 0.5, NaH2PO4 0.3, 
and HEPES 10 titrated to pH 7.40 with 1 mol/L NaOH. Individual cell strands were stimulated with a 
bipolar electrode consisting of a glass micropipette filled with HBSS and a silver wire coiled around the 
shank. The electrode was placed ≥ 1 mm from measurement site in order to permit propagation to reach 
steady-state conditions at the recording site. Individual strands were pre-stimulated for 10s by a stimulator 
(SD9, Grass Instruments Co., Quincy, MA) at a basic cycle length of 500 ms before recording a single 
propagating action potential using a custom made fiberoptic recording system described in detail 
elsewhere.2 Recordings were made at 20x magnification (Fluar 20x, 0.75 N.A., Zeiss, Switzerland) 
resulting in a spatial resolution of 50 µm. The amplitude of optically recorded action potential upstrokes 
were scaled to 100% (%APA). Maximal upstroke velocities (dV/dtmax) were calculated from %APA 
values and are given in %APA/ms. With an assumed action potential amplitude of 100 mV, %APA/ms 
values correspond to V/s. Activation profiles of the preparations were assessed from the time when 
depolarization reached 50% of the entire action potential amplitude.  
 
Longterm assessment of ectopic activity 
Because extracellular multielectrode arrays failed to record spontaneous electrical activity in 
myofibroblast coated cardiomyocyte cultures due to the partially depolarized state of the preparations, we 
developed a prototype measurement system that permitted to record ectopy-induced contractile activity 
instead. Continuous recordings of contractions were obtained with a video camera (Sony XCD-V60; 
resolution: 640x480 pixels; 90 frames per second) coupled to an inverted microscope (Zeiss, Axiovert 
S100) that was equipped with phase contrast optics. The entire system was placed in an incubator to 
ensure stable environmental conditions during the entire recording period (up to 48 h). Preparations 
placed in multiwell dishes were imaged at 10x magnification and positions were changed by means of a 
motorized x-y table. Contraction signals were calculated from the video data by realtime subtraction of 
consecutive images followed by thresholding and by summing intensity differences as recorded by each 
pixel. This algorithm permitted unequivocal identification of synchronized contractions of the cell 
monolayers with high signal-to-noise ratios. A semi-automatic detection algorithm identified the 
contractions and, after assessing beat-to-beat periods, calculated average beat rates as shown in Figure 4 
of the manuscript. At the end of each recording of a given preparation, a picture was taken to permit 
offline construction of time-lapse movies. 
 
Patch clamp recordings 
Electrophysiological parameters of cardiomyocytes and myofibroblasts were measured using a HEKA 
patch clamp system (EPC-10 amplifier, HEKA) with experimental protocols controlled by PatchMaster 
software (v2.15, HEKA). The pipette filling solution contained (in mmol/L): K-aspartate 120, NaCl 10, 
MgATP 3, CaCl2 1, EGTA 10, Hepes 5 (pH 7.2). Pipette resistances ranged from 4 to 6 MΩ and pipette 
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potentials were zeroed before cell contact. Digitized signals were stored for off-line analysis using 
PatchMaster or FitMaster (v2.53, HEKA). Membrane voltages were corrected offline for liquid junction 
potentials as calculated by pCLAMP software (Axon Instruments). During measurements, low density 
cell cultures were mounted in a custom-made chamber 3 that was placed on the stage of an inverted 
microscope (Nikon eclipse, TE2000-E). Preparations were superfused with Hank’s balanced salt solution 
containing 1% neonatal calf serum (pH 7.40, buffered with 10 mmol/L Hepes) at 2-3 ml/min at RT. 
Resting membrane potentials were recorded in single CMCs, single MFBs or in CMC-MFB hybrid cell 
pairs in current clamp mode. Voltage clamp experiments using both step and ramp protocols were used to 
measure net membrane currents in single CMCs or MFBs. During step protocols, cells were clamped for 
1000 ms from -100 to 60 mV in 10 mV increments starting from a holding potential of -80 mV. For 
obtaining I-V relationships of MFBs, 2000 ms long voltage ramps (-110 to 90 mV) were applied from a 
holding potential of -70 mV. The amplitude of whole cell net membrane currents where normalized to 
cell capacitance and are reported as pA/pF.  
 
Dye coupling 
The presence of functional intercellular coupling between CMCs and MFBs was probed with the gap 
junction permeable dye Lucifer yellow (concentration in pipette solution: 2 mmol/L). Dye diffusion was 
assessed 8 min after establishing successful patches on CMCs coupled to MFBs at which time a 
fluorescence image was taken with a CCD camera (Macrofire, Optronics). After each experiment, 
preparations were usually subjected to immunocytochemistry to verify that the cells coupled to CMCs 
were indeed MFBs (positive staining for α-smooth muscle actin containing stress fibers). 
 
RT-qPCR 
Expression levels of ion channel genes in cardiac myofibroblasts were determined using the 7900HT 
Micro Fluidic Card system from Applied Biosystems. TaqMan® Low Density Arrays pre-loaded with a 
customized selection of standardized primer pairs permitted the quantitative determination of the 
expression levels of 70 genes of interest (reference genes: GAPDH, Hprt1, 18S). 
Total RNA was isolated from 6 independent cultures of myofibroblasts that had been grown according to 
the protocols used for generating hybrid cell preparations, i.e., adherent cells obtained during the 
preplating step were kept for 8 days in culture before being split and subjected to a second preplating 
procedure in order to efficiently remove 'contaminating' cardiomyocytes. Thereafter, cells were kept for 
another 24 h in culture before undergoing a medium exchange with control medium or with medium 
containing 1 µmol/L Cytochalasin D.  Then, cell lysis was performed and the quality and quantity of the 
total extracted RNA was determined photometrically (NanoDrop Technologies). Corresponding cDNA 
was obtained using a high capacity RNA-to-cDNA Kit (Applied Biosystems). Finally, a two-step RT-
PCR was performed using a TaqMan® Universal Master Mix II. Analysis of the data was performed 
using RT2 software (SABiosciences). 
 
Western blotting 
Total cell lysate was obtained from cardiac myofibroblasts cultured according to the protocol used for 
RT-qPCR. After the final 24 h of incubation in control medium or medium containing 1 µmol/L 
Cytochalasin D, cells were harvested on ice, rinsed twice with cold PBS and incubated on ice with lysis 
buffer for 10 min (NP40 Lysis Buffer, Invitrogen, CA, USA) supplemented with protease inhibitors 
(Complete mini, Roche, Germany). Cells were scraped and collected into a microcentrifuge tube, 
vortexed and centrifuged at 13,000 rpm for 5 min. The cell supernatant was kept and the sediment 
containing cell membranes was discarded. Protein concentration in the supernatant was quantified using a 
protein assay quantification kit (BCA Protein Kit Assay, Thermo Scientific, IL, USA). From each sample, 
20µg was loaded and run on an 8% SDS-PAGE gel and then transferred to PVDF membranes. 
Membranes were incubated overnight at 4°C with the following primary antibodies at a dilution of 1/200 
in TBS-blocking solution: rabbit polyclonal antibodies against GAPDH, TRPM4, TRPV4 (Abcam, 
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Cambridge, UK), TRPC3, TRPV2 and Kv2.1 (Alomone Labs, Jerusalem); rabbit monoclonal antibodies 
against Kir2.1 (Abcam) and mouse monoclonal antibodies against Kir2.3 (Abcam).  The membranes were 
then rinsed with TBS-Tween 0.1% and incubated for 1 hour at room temperature with secondary 
antibodies coupled to an infrared chromophore (anti-mouse 700DX and anti-rabbit 800nm, Rockland, PA, 
USA) at a dilution of 1/10,000 in TBS-blocking solution. After being rinsed, the membranes were 
assessed using an infrared imager (Odyssey, Li-Cor Biosciences, NE, USA) and analysed using ImageJ 
software. 
 
 
Online Data, Figures and Movies 
 
Timecourse of changes in myofibroblast morphology during exposure to actin targeting drugs 
Gradual changes in cellular morphology of myofibroblasts subjected to acting targeting drugs were 
assessed using time-lapse recordings of myofibroblast-only monolayer cultures grown on collagen-coated 
coverslips. As shown in Online Movie 1 and the first row of still-images from this movie in Online Figure 
I, cell morphology of myofibroblast cultures undergoing a control medium exchange remained essentially 
unchanged over the entire observation period (~ 20 h) despite the rather dynamical behavior of 
myofibroblasts that showed substantial locomotion and cell division (dividing myofibroblasts can be 
easily identified because they transiently loose their flattened shape and become spherical before division 
occurs). When exposed to CytoD (100 nmol/L), myofibroblasts tended to become spherical (cf. Online 
Movie 2 and red arrows in the second row of panels in Online Figure I) before regaining a flattened 
morphology in the continued presence of the drug.  Highly similar morphological changes were observed 
during exposure to LatB (100 nmol/L). However, this particular compound acted faster (cells started to 
become spherical a few minutes after drug addition) and concerned nearly all cells (cf. Online Movie 3 
and red arrows in the third row of panels in Online Figure I). Again, changes in cellular morphology were 
transient as cells tended to regain their flattened morphology in the continued presence of the drug 
towards the end of the observation period. In contrast to CytoD and LatB, Jasp showed no acute effects 
on cell morphology but caused increasingly severe morphological changes with progressive retraction of 
cells and induction of complete disarray of their cytoplasmic extension. These changes showed no 
tendency to reverse with increasing exposition time (cf. Online Movie 4 and the last row of images in 
Online Figure I).  
Overall, morphological changes induced by actin targeting drugs in myofibroblast monolayers cultured on 
glass substrates were highly similar to those observed in hybrid cell cultures. Interestingly, the timecourse 
with which actin targeting drugs induced changes in myofibroblast morphology paralleled the timecourse 
of their suppressive effect on ectopic activity: LatB, that exhibited acute effects on myofibroblast 
morphology, similarly led to an acute depression of the frequency of ectopic activations whereas CytoD 
and even more so Jasp, whose effects on myofibroblast morphology were delayed, also showed a delay in 
suppressing ectopic activity (CytoD < Jasp). This suggests that changes in myofibroblast morphology 
were related to changes in emergent electrophysiological properties of hybrid cardiomyocyte-
myofibroblast preparations. A full understanding of this interrelation will require future studies into the 
mechanisms that determine structure-function relationships at the molecular level in myofibroblasts. 
 
Membrane potentials in hybrid cell pairs: Theoretically predicted and measured values 
Upon establishment of functional gap junctional coupling between myofibroblasts and cardiomyocytes, 
current flow between the two cells exhibiting different resting potentials will cause membrane potentials 
to converge. The degree to which this happens is dependent, at first approximation, on the relative sizes of 
the input resistances of the two cell types (riCMC, riMFB) and the resistance of gap junctional coupling (rGJ, 
for extended formulations cf. 4). We determined input resistances in cultured cardiomyocytes and 
myofibroblasts to be 240 ± 70 MOhm and 1200 ± 440 MOhm, respectively (all data from preparations of 
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Figure 7 of the manuscript). Average gap junctional resistance in 6 hybrid cell pairs measured with dual 
whole cell patch clamp protocols amounted to 125 MOhm. The voltage gradient between CMCs and 
MFBs under control conditions was 48 mV (VmCMC: -74.6 ± 3.3 mV, VmMFB: -26.6 ± 7.2 mV). Upon 
establishment of gap junctional coupling, this voltage will drop across the serially arranged resistors 
(riMFB - rGJ - riCMC) according to their relative sizes. Based on these considerations, CMCs are predicted to 
undergo a depolarization by 7.4 mV to -67.2 while myofibroblasts will undergo a hyperpolarization by 
36.8 mV to -63.4 mV. For CMCs, this value is less depolarized than the actually measured value (-63.0 
mV) but is well within the standard deviation of these determinations (±12 mV, n= 17). For the case of 
CytoD treated preparations (VmCMC: -73.3 ± 3.0 mV, VmMFB: -44.3 ± 12.3 mV; riMFB: 3610 ± 670 
MOhm) and under the assumption that riCMC and rGJ remained unchanged, the resting potential of CMCs 
following gap junctional coupling is predicted to decrease by 1.7 mV to -71.6 mV which is in agreement 
with measured values (-72.5 ± 10.3 mV). 
 
Ion channel gene expression 
The expression of ion channels genes potentially involved in myofibroblast electrophysiology with a 
specific focus on genes potentially associated with hyperpolarization following exposure to CytoD, is 
depicted in Online Table I (list of gene targets investigated), Online Figure II (22 Trp channel genes), 
Online Figure III (25 potassium channel related genes), Online Figure IV (11 chloride channel related 
genes), Online Figure V (9 pumps and exchanger related genes) and Online Figure VI (connexins, α-
SMA). Among the 70 genes tested, expression was either non-detectable (10 genes), remained unchanged 
(5 genes), showed a trend towards a decrease (41 genes) or was increased (14 genes) by CytoD treatment. 
Changes were moderate and reached significance only for K2P3.1 (increase). Variability in expression 
was generally larger in treated preparations than in controls which may point to culture-to-culture 
variations in responsivity to CytoD treatment. Among the 47 Trp and K+ channels tested which are the 
most likely candidates for CytoD related changes in myofibroblast electrophysiology, 2 genes were 
highly expressed (Ct < 25), 9 were moderately expressed (Ct < 25-30) and 31 showed low expression (Ct 
30-35). For 5 genes, no expression could be detected. The group of highly/moderately expressed genes 
consisted of Trpm7, Trpc6, Trpv2, Trpc1, Trpm4, Trpc2, Trpv4 and Kv4.3, K2P2.1, Kv2,1 and Kir2.1. 
Among the Trp channels, CytoD induced a reduction of expression in 6 out of seven channel genes that, 
even though being non-significant, may contribute to the CytoD induced myofibroblast hyperpolarization 
by reducing non-specific cation inward currents. In parallel, however, CytoD also reduced expression of 
the highly/moderately expressed potassium channels which would be expected to counteract the 
suppression of Trp channel expression. On the other hand, CytoD caused an upregulation of expression of 
K2P3.1 (significant), Kir1.1, Kv1.2, Kir3.1, Kir3.3 to Ct values <30 (moderate expressed channels) which 
may tip the balance again towards myofibroblasts hyperpolarization. Expression of chloride transporters, 
chloride channels, sodium-potassium pump subunits and sodium-calcium exchangers tended to be slightly 
decreased by CytoD treatment. This was also the case for α-SMA and Cx43 and 45 expression. Overall, 
the RT-qPCR findings suggest that CytoD, apart from inducing a slight reduction of gene expression in 
the majority of genes tested, had little consistent effect that would unambiguously explain the changes in 
myofibroblast electrophysiology following exposure to CytoD. Nevertheless, the wide screen of ion 
channels and transporters expressed in cultured myofibroblasts of cardiac origin may serve as a basis for 
future investigations into the molecular basis of the electrophysiology exhibited by this cell type 
important in cardiac disease. In this respect, it is worth noting that the profile of Trp channel gene 
expression found in the present study is highly similar to the profile reported recently for human atrial 
fibroblasts (robust expression of Trpc1, Trpc 6, Trpv2, Trpv4 and Trpm7) with Trpm7, as in our study, 
showing the highest level of expression that was further upregulated in fibroblasts from AF patients.5 
These similarities suggest that cultured cardiac myofibroblasts may constitute a useful model for the 
investigation of molecular mechanisms governing adverse crosstalk with cardiomyocytes in diseased 
hearts. 
 
 
  6 
 
Western blot results 
In order to identify ion channels possibly responsible for the observed changes in myofibroblast 
electrophysiology following exposure to CytoD (1 µmol/L for 24 h), we performed western blots. The 
channels chosen, TRPC3, TRPM4, TRPV2, TRPV4, Kv2.1, Kir2.1 and Kir2.3, were shown in previous 
studies to be expressed by fibroblastic cells of cardiac origin and to be involved in setting the membrane 
potential.5-12 Similar to the RT-qPCR results and as shown in Online Figure VII, we were unable to detect 
significant differences of expression between control and CytoD treated preparations for TRPM4, 
TRPV2, TRPV4, Kv2.1, Kir2.1 and Kir2.3. RT-qPCR and western blot results were qualitatively similar 
for TRPC3, TRPV2, Kv2.1 (all slightly reduced), TRPV4 (unchanged) and Kir2.3 (slight upregulation). 
TRPM4 and Kir2.1 showed a discordant behavior. 
In contrast to all other channels, TRPC3 showed a migration profile that was dependent on CytoD 
treatment. The expected size of this protein is ~ 97 kDa, thus corresponding to the band just below the 
100 kDa protein size marker. The upper band (slightly above 100 kDa) represents the complex 
glycosylated form of the TRPC3 channel protein which importantly determines channel activity and 
cellular targeting as reported by others before.13-15 The significant reduction of this band following 
treatment suggests that CytoD affected glycosylation and hence channel function at the post translational 
level. Being a nonselective Ca2+ permeable cation channel, a reduction of TRPC3 activity might 
contribute to a hyperpolarizing shift of the membrane potential observed in myofibroblasts following 
CytoD exposure. Clearly, definite proof of such a mechanism requires additional investigations that 
elucidate quantitative aspects of a change in TRPC3 glycosylation on the myofibroblast membrane 
potential. Also, such investigations would have to show whether and by which mechanisms the CytoD-
induced disruption of α-SMA-SFs relate to a change in TRPC3 glycosylation.  
In summary and similar to the RT-qPCR results, western blots of a subset of ion channels present in 
cardiac fibroblastic cells failed  to give definite answers as to the molecular identity of ion channel(s) 
involved in the CytoD induced hyperpolarization that accompanied the phenotype reversal from 
myofibroblasts to fibroblasts. The results suggest that in addition to the possibility of modifications of ion 
channel trafficking and targeting, post translational modifications might contribute to changes in cellular 
electrophysiology accompanying the phenotype reversal. 
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Online Movie Legends 
 
Online Movie 1: Time-lapse movie showing changes in cellular morphology of a control myofibroblast 
monolayer culture during an observation period of 20 h. The first frame after the control medium 
exchange is taken at 26:13:55 (~ 1.5 h after start of the recording). The imaged area measures 460 x 340 
µm. 
Online Movie 2: Time-lapse movie of changes in cellular morphology after exposure of myofibroblast 
monolayer cultures to 100 nmol/L CytoD. The first frame after the control medium exchange is taken at 
26:24:33 (~ 1.5 h after start of the recording). The imaged area measures 460 x 340 µm. 
Online Movie 3: Time-lapse movie of changes in cellular morphology after exposure of myofibroblast 
monolayer cultures to 100 nmol/L LatB. The first frame after the control medium exchange is taken at 
26:23:47 (~ 1.5 h after start of the recording). The imaged area measures 460 x 340 µm. 
Online Movie 4: Time-lapse movie of changes in cellular morphology after exposure of myofibroblast 
monolayer cultures to 1 µmol/L Jasp. The first frame after the control medium exchange is taken at 
26:25:18 (~ 1.5 h after start of the recording). The imaged area measures 460 x 340 µm. 
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Online Figure I: Still images from time-lapse movies 1-4 that show the morphology of myofibroblast 
monolayer cultures 1.5 h before and 1 and 18 h after a medium exchange containing either no drugs 
(control), 100 nmol/L CytoD, 100 nmol/L LatB, or 1 µmol/L Jasp. Red arrows point to myofibroblasts 
that lost their flattened morphology and became spherical during drug treatment either transiently (CytoD 
and LatB) or permanently (Jasp). 
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Online Table I: List of ion channel genes investigated with RT-qPCR in control myofibroblasts and 
myofibroblasts exposed for 24 h to 1 µmol/L Cytochalasin D. 
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Online Figure II: RT-qPCR results of TRP channel gene expression in control myofibroblasts (black 
columns) and myofibroblasts treated with 1µmol/L Cytochalasin D for 24 h (grey columns; mean ± S.D 
of 5 separate cultures). Empty columns: no gene expression detected.
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Online Figure III: RT-qPCR results of potassium channel gene expression in control myofibroblasts 
(black columns) and myofibroblasts treated with 1µmol/L Cytochalasin D for 24 h (grey columns; mean ± 
S.D of 5 separate cultures). Empty columns: no gene expression detected. 
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Online Figure IV: RT-qPCR results of chloride channel gene expression in control myfibroblasts (black 
columns) and myofibroblasts treated with 1µmol/L Cytochalasin D for 24 h (grey columns; mean ± S.D 
of 5 separate cultures). Empty columns: no gene expression detected. 
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Online Figure V: RT-qPCR results sodium-potassium ATPase and sodium-calcium exchanger gene 
expression in control myfibroblasts (black columns) and myofibroblasts treated with 1µmol/L 
Cytochalasin D for 24 h (grey columns; mean ± S.D of 5 separate cultures). Empty columns: no gene 
expression detected. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Online Figure VI: RT-qPCR results of connexin43/45 and α-SMA gene expression in control 
myofibroblasts (black columns) and myofibroblasts treated with 1µmol/L Cytochalasin D for 24 h (grey 
columns; mean ± S.D of 5 separate cultures). 
 
 
 
 
  14 
 
 
 
 
 
 
Online Figure VII: Western-blot analysis of the differential expression of 7 ion channel proteins in 
myofibroblasts undergoing treatment with Cytochalasin D. Migration patterns: left, control 
myofibroblasts; right: Cytochalasin D treated myofibroblasts (1 µmol/L for 24 h). Graphs: protein 
expression levels (normalized to GAPDH) of each protein in CytoD treated condition (Cyto-D) 
normalized to controls (Ctrl). Each column represents the mean ± S.D. of 3 different experiments. 
TRPC3: upper bands correspond to glycosylated form of the channel protein. *P<0.05= significantly 
different from control. 
 
 
 
 
 
 
 
 
 
 
 
